Cargando…
Harnessing the Therapeutic Potential of Ginsenoside Rd for Activating SIRT6 in Treating a Mouse Model of Nonalcoholic Fatty Liver Disease
[Image: see text] Nonalcoholic fatty liver disease (NAFLD) is a prevalent global condition and a common precursor to liver cancer, yet there is currently no specific medication available for its treatment. Ginseng, renowned for its medicinal and dietary properties, has been utilized in NAFLD managem...
Autores principales: | Cui, Tianqi, Xiao, Xiaoxia, Pan, Zhisen, Tang, Kaijia, Zhong, Yadi, Chen, Yingjian, Guo, Jingyi, Duan, Siwei, Zhong, Guangcheng, Li, Tianyao, Li, Xiang, Wu, Xiumei, Lin, Chuanquan, Yang, Xiaoying, Gao, Yong, Zhang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433470/ https://www.ncbi.nlm.nih.gov/pubmed/37599957 http://dx.doi.org/10.1021/acsomega.3c04122 |
Ejemplares similares
-
Ginsenoside Rc, as an FXR activator, alleviates acetaminophen-induced hepatotoxicity via relieving inflammation and oxidative stress
por: Zhong, Yadi, et al.
Publicado: (2022) -
Hepatic SIRT6 Modulates Transcriptional Activities of FXR to Alleviate Acetaminophen-induced Hepatotoxicity
por: Liu, Changhui, et al.
Publicado: (2022) -
Microglia Sirt6 modulates the transcriptional activity of NRF2 to ameliorate high-fat diet-induced obesity
por: Xiao, Xiaoxia, et al.
Publicado: (2023) -
Correction: Microglia Sirt6 modulates the transcriptional activity of NRF2 to ameliorate high-fat diet-induced obesity
por: Xiao, Xiaoxia, et al.
Publicado: (2023) -
Ginsenoside Rc attenuates DSS-induced ulcerative colitis, intestinal inflammatory, and barrier function by activating the farnesoid X receptor
por: Tang, Kaijia, et al.
Publicado: (2022)